States Want Control Over Drug Prices. Will the Feds Give It to Them?

Governing: While Congress remains gridlocked on health-care reforms -- particularly regarding drug prices -- states are increasingly taking matters into their own hands.

In September, Massachusetts submitted a waiver to the Centers for Medicare and Medicaid Services (CMS) that asks permission to exclude certain drugs from its Medicaid program, MassHealth.

It’s a bold step, says Tom Dehner, Massachusetts' former Medicaid director. The move, he says, is an attemp to "take the next step in managing costs."

Read article

Share

i360Gov Newsletters

The most significant government policy, business, and technology news and analysis delivered to your inbox.

Subscribe Now

Trending